Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $393.22 million. The enterprise value is $255.66 million.
Important Dates
The next estimated earnings date is Saturday, May 24, 2025, before market open.
Earnings Date | May 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.66 million shares outstanding. The number of shares has increased by 569.30% in one year.
Current Share Class | 18.66M |
Shares Outstanding | 18.66M |
Shares Change (YoY) | +569.30% |
Shares Change (QoQ) | +0.43% |
Owned by Insiders (%) | 40.37% |
Owned by Institutions (%) | 39.17% |
Float | 9.73M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.23 |
P/TBV Ratio | 2.80 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.65, with a Debt / Equity ratio of 0.02.
Current Ratio | 12.65 |
Quick Ratio | 12.17 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -542.20 |
Financial Efficiency
Return on equity (ROE) is -84.79% and return on invested capital (ROIC) is -50.22%.
Return on Equity (ROE) | -84.79% |
Return on Assets (ROA) | -37.71% |
Return on Invested Capital (ROIC) | -50.22% |
Return on Capital Employed (ROCE) | -41.06% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.14M |
Employee Count | 51 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.55% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +47.55% |
50-Day Moving Average | 22.09 |
200-Day Moving Average | 30.27 |
Relative Strength Index (RSI) | 54.74 |
Average Volume (20 Days) | 251,353 |
Short Selling Information
The latest short interest is 1.10 million, so 5.92% of the outstanding shares have been sold short.
Short Interest | 1.10M |
Short Previous Month | 882,379 |
Short % of Shares Out | 5.92% |
Short % of Float | 11.36% |
Short Ratio (days to cover) | 1.44 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -58.02M |
Pretax Income | 30.68M |
Net Income | -57.98M |
EBITDA | -56.37M |
EBIT | -58.02M |
Earnings Per Share (EPS) | -$6.83 |
Full Income Statement Balance Sheet
The company has $141.24 million in cash and $3.30 million in debt, giving a net cash position of $137.94 million or $7.39 per share.
Cash & Cash Equivalents | 141.24M |
Total Debt | 3.30M |
Net Cash | 137.94M |
Net Cash Per Share | $7.39 |
Equity (Book Value) | 140.78M |
Book Value Per Share | 9.48 |
Working Capital | 135.25M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$59.08 million and capital expenditures -$156,000, giving a free cash flow of -$59.24 million.
Operating Cash Flow | -59.08M |
Capital Expenditures | -156,000 |
Free Cash Flow | -59.24M |
FCF Per Share | -$3.17 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |